Navigation Links
Pharmaxis Announces Placement of $50 Million and Share Purchase Plan
Date:10/10/2007

CN 082 811 630) is a specialist pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory and immune disorders. Its development pipeline of products include Aridol for the management of asthma, Bronchitol for cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease (COPD) and PXS64 for the treatment of multiple sclerosis.

Founded in 1998, Pharmaxis is listed on the Australian Stock Exchange (symbol PXS), and on NASDAQ Global Market (symbol PXSL). The company is headquartered in Sydney at its TGA-approved manufacturing facilities. For more information about Pharmaxis, go to http://www.pharmaxis.com.au or contact Jane Sugden, Investor Relations +61 2 9454 7230.

Forward-Looking Statements

The statements contained in this media release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this media release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. We can not guarantee that any product candidate will receive FDA or other regulatory approval or that we will seek any such approval. Factors that could cause or contribute to such differences include, but are not limited to, factors discussed in the "Risk Factors and Other Uncertainties" section of our Form 20-F lodged with the U.S. Securities and Exchange Commission.


'/>"/>
SOURCE Pharmaxis Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... PathoGenetix, Inc., a commercial-stage developer of an ... that it has successfully identified and strain typed a ... the Centers for Disease Control and Prevention (CDC) using ... are detailed in a poster presented at ... in Denver on Monday. , The 250 E. coli ...
(Date:5/20/2013)... Ras Al Khaimah, UAE (PRWEB) May 21, 2013 ... and private equity consultancy specializing in “game-changing” life science ... appointment of Ms. Dalia Dergham to its International Project ... certain to bring even greater multi-cultural depth to Grace ... more projects around the globe. , Ms. Dergham holds ...
(Date:5/20/2013)... , May 20, 2013  (PSHR) Pacific ... naturally based products across a broad range of ... has retained investor relations firm, BlueWater Advisory Group, ... return to trading process, and to direct the ... initiation. Matthew Mills ...
(Date:5/20/2013)... BALTIMORE , May 20, 2013 /PRNewswire/ ... private-public partnership focusing on commercializing market-relevant biohealth innovations ... Central Maryland , today announced its ... first Entrepreneur-in-Residence (EIR) for BHI at the National ... and Blood Institute (NHLBI). Dr. Aiyar will ...
Breaking Biology Technology:New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4
... a biopharmaceutical company developing novel and biosuperior protein therapeutics ... appointed James A. Wells, Ph.D., and James R. Swartz, ... Prof. Wells will serve as Chairman of the SAB. ... experts in the field of protein engineering to provide ...
... announced today that it has secured $47.5 million in ... the financing along with existing investors OrbiMed Advisors, New ... the financing, Josh Bilenker, M.D., Partner at Aisling Capital, ... this round will support commercialization of the company,s Atlas™ ...
... Colo., Jan. 6, 2012 LABS, Inc., a global, ... expertise in regulated testing for human organs, cells, tissues ... it has been granted AABB Accreditation for donor testing. ... safety of collecting, processing, testing, distributing and administering blood ...
Cached Biology Technology:Sutro Announces Newly Formed Scientific Advisory Board 2Sutro Announces Newly Formed Scientific Advisory Board 3Roka Bioscience Secures $47.5 Million in Series D Financing 2LABS, Inc. Earns AABB Accreditation for Donor Testing 2
(Date:5/17/2013)... College study finds human-caused climate change may have ... contradicting a host of recent studies that predict ... , The findings, which appear in the journal ... for survival of a creature thought to be ... tropical cold-blooded animals, especially forest lizards, will be ...
(Date:5/17/2013)... An international team of scientists using a ... movement inside a living frog embryo in greater detail ... to advance biological research and the search for new ... the Karlsruher Institut fr Technologie in Germany, in collaboration ... of Energy,s Argonne National Laboratory, released the most precise ...
(Date:5/16/2013)... to Research Careers) Program has announced the travel ... Annual Meeting in San Francisco, CA from June ... the entry of students, postdoctorates and scientists from ... science community and to encourage the participation of ... , Awards are given to poster/platform presenters and ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2New X-ray method shows how frog embryos could help thwart disease 2
... isnt the only way that carbon monoxide (CO) damages ... According to the findings of a new study, ... CO also causes direct damage to the heart muscle, ... the hearts pumping capacity and permanently impairs cardiac function. ...
... 29, 2008 A Canada-U.S. research team has found ... decline of water quality in coastal waters. In the ... Caraco explain that the collapse of the fisheries from ... in disturbing the balance between nitrogen entering and leaving ...
... a $1.8 million grant from the W.M. Keck Foundation ... and dramatic transformations that occur in processes where small-scale ... include the breakup of splashing water droplets, the sudden ... occur in a dividing cell. The University has ...
Cached Biology News:Carbon monoxide may cause long-lasting heart damage 2Bad news for coastal ocean: less fish out, means more nitrogen in 2University of Chicago launches research program in catastrophic deformation 2University of Chicago launches research program in catastrophic deformation 3
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
... raised against a partial recombinant ... TOPORS (NP_005793, 98 a.a. ... protein with GST tag. ... NM_005802 Protein ...
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Biology Products: